Key facts
- It has raised $14.9M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Shanghai Zhangjiang Science & Technology Venture Capital, Century Golden Resources Group, Y.R.Delta Fund, Jinan International Medical Center Industrial Development, AnlongMed — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for ArtechMed
- ·The full record, as it builds
Funding rounds
No funding rounds for ArtechMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ArtechMed
Developer of medical equipment and supplies designed to simplify and improve the safety of the treatment of atrial fibrillation. The company's new generation of Cryoballoon Ablation (CBA) and Pulsed Field Ablation (PFA) technology and products are designed to be minimally invasive for interventional treatment of atrial fibrillation, enabling doctors to reduce risks for the patients.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2017
- Website
- artechmed.com/
- Ownership
- Privately Held (backing)
ArtechMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ArtechMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ArtechMed in its N-PORT filings yet. We sweep new filings monthly.